phase 1_completion
saveDaewoong Therapeutics Inc — semaglutide (Phase I Trial Completion)
community read0 votes
Therapy area: Metabolic Disorders. Indication: Diabetes, Obesity, Overweight, Type 2 Diabetes
Data sources
globaldata
Found something off?
drug timeline · 1
related news · 8
- biopharma diveLilly data point to ‘maintenance’ strategies for GLP-1 weight loss
- statSTAT+: Pharmalittle: We’re reading about FDA’s Makary resigning, a Lilly weight loss drug trial, and more
- statSTAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and more
- endpointsRezdiffra is exceeding Wall Street's expectations as the MASH market takes shape
- endpointsAmazon adds Ozempic pill to same-day prescription drug kiosks
- endpointsEntrada stock falls on Duchenne data; Wegovy expands access
- statSTAT+: FDA revisits a rare cancer treatment it rejected a few months ago
- statSTAT+: FDA to reconsider treatment for rare cancer after its surprise rejection
🐶 often sniffed alongside
top 8- drugOzempic168 co-mentions · 74 sources
- drugWegovy168 co-mentions · 74 sources
- tagApproval124 co-mentions · 44 sources
- drugRybelsus94 co-mentions · 72 sources
- drugsemaglutide94 co-mentions · 72 sources
- tagRecall33 co-mentions · 27 sources
- companyNovo Nordisk Inc22 co-mentions · 3 sources
- tagSmall Molecule22 co-mentions · 18 sources
comments(0)
5-min edit window · permanent after that